- Section 1 - About the Company
- Emergent BioSolutions Inc - Key Facts
- Emergent BioSolutions Inc - Key Employees
- Emergent BioSolutions Inc - Key Employee Biographies
- Emergent BioSolutions Inc - Major Products and Services
- Emergent BioSolutions Inc - History
- Emergent BioSolutions Inc - Company Statement
- Emergent BioSolutions Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Emergent BioSolutions Inc - Business Description
- Business Segment: Commercial Products
- Overview
- Performance
- Business Segment: Contracts and grants
- Performance
- Business Segment: MCM Products
- Overview
- Performance
- Business Segment: Services
- Overview
- Performance
- Geographical Segment: Canada
- Performance
- Geographical Segment: Others
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- Emergent BioSolutions Inc - Corporate Strategy
- Emergent BioSolutions Inc - SWOT Analysis
- SWOT Analysis - Overview
- Emergent BioSolutions Inc - Strengths
- Emergent BioSolutions Inc - Weaknesses
- Emergent BioSolutions Inc - Opportunities
- Emergent BioSolutions Inc - Threats
- Emergent BioSolutions Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Emergent BioSolutions Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Sep 25, 2024: Emergent Biosolutions Confirms Approximately $400 Million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
- Sep 12, 2024: Emergent Biosolutions Awarded Research and Development Option Valued at $41.9 Million for Continued Advanced Development and Procurement of Ebanga Treatment for Ebola
- Jul 02, 2024: Emergent Biosolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
- May 01, 2024: Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
- May 01, 2024: Emergent BioSolutions Reports First Quarter 2024 Financial Results
- Mar 25, 2024: Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
- Mar 06, 2024: Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
- Feb 21, 2024: Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
- Jan 09, 2024: Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
- Oct 02, 2023: Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Emergent BioSolutions Inc, Key Facts
- Emergent BioSolutions Inc, Key Employees
- Emergent BioSolutions Inc, Key Employee Biographies
- Emergent BioSolutions Inc, Major Products and Services
- Emergent BioSolutions Inc, History
- Emergent BioSolutions Inc, Other Locations
- Emergent BioSolutions Inc, Subsidiaries
- Emergent BioSolutions Inc, Joint Venture
- Emergent BioSolutions Inc, Key Competitors
- Emergent BioSolutions Inc, Ratios based on current share price
- Emergent BioSolutions Inc, Annual Ratios
- Emergent BioSolutions Inc, Annual Ratios (Cont...1)
- Emergent BioSolutions Inc, Annual Ratios (Cont...2)
- Emergent BioSolutions Inc, Interim Ratios
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Emergent BioSolutions Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Emergent BioSolutions Inc, Performance Chart (2019 - 2023)
- Emergent BioSolutions Inc, Ratio Charts
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Emergent BioSolutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook